No Data
No Data
Xuerong Biology (300511.SZ): In 2023, the production of enoki mushrooms was 366,700 tons, and the production of shimeji mushrooms was 81,700 tons
Shanghai Xuerong Bio-Technology (300511.SZ) stated on the investor communication platform that the company's main raw materials include rice bran, corn cob, bran, cottonseed hulls, beer dregs, etc. The company's suppliers are widely distributed and numerous, and there is no reliance on a single supplier. In 2023, the company's production of shiitake mushrooms was 366,700 tons, and the production of enoki mushrooms was 81,700 tons.
Shanghai Xuerong Bio-technology (300511.SZ): focuses on the research and development, factory production, and sales of fresh edible mushrooms.
Shanghai Xuerong Bio-Technology (300511.SZ) stated on the investor interaction platform on June 7th that the company's main business is the research and development, factory cultivation, and sales of fresh edible mushrooms. The company's products are mainly sold through dealers and directly sold to channels such as supermarket systems, chain dining systems, and fresh delivery platforms. The company will continue to actively develop domestic and foreign markets.
Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Price Is Right But Growth Is Lacking After Shares Rocket 28%
Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) shareholders would be excited to see that the share price has had a great month, posting a 28% gain and recovering from prior weakness. Unfortu
Even After Rising 31% This Past Week, Shanghai Xuerong BiotechnologyLtd (SZSE:300511) Shareholders Are Still Down 50% Over the Past Five Years
It is a pleasure to report that the Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) is up 45% in the last quarter. But if you look at the last five years the returns have not been good. You
Xuerong Biotech (300511.SZ) reported first-quarter results, net profit of 5.2403 million yuan, a year-on-year decrease of 97.65%
Xuerong Biotech (300511.SZ) released its report for the first quarter of 2024. The company achieved operating income during the reporting period...
Xuerong Biotech (300511.SZ) holds 1.96% shareholder Zhu Huancheng plans to liquidate and reduce holdings
Xuerong Biology (300511.SZ) announced that Zhu Huancheng, a specific shareholder of the company, plans to make three transactions from the date of publication of this announcement...
No Data